Evidence map›Paper›PMID 36560419›Full record

ArticleVaccines2022

Perception of Availability, Accessibility, and Affordability of COVID-19 Vaccines and Hesitancy: A Cross-Sectional Study in India.

Akshay Ayappan, Bijaya Kumar Padhi, Ananthesh L, Raushan Kumar Chaudhary, Uday Venkat Mateti, Adithi Kellarai, Mazhuvanchery Kesavan Unnikrishnan, Jaclyn Drishal Dsouza, Ali Davod Parsa, Russell Kabir and 1 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Akshay AyappanDepartment of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangaluru 575018, India.ORCID 0000-0002-5046-4781
Bijaya Kumar PadhiDepartment of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.ORCID 0000-0002-2828-2375
Ananthesh LDepartment of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangaluru 575018, India.ORCID 0000-0002-2667-7234
Raushan Kumar ChaudharyDepartment of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangaluru 575018, India.ORCID 0000-0002-5862-3636
Uday Venkat MatetiDepartment of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangaluru 575018, India.ORCID 0000-0001-8149-2067
Adithi KellaraiDepartment of General Medicine, KS Hegde Medical Academy (KSHEMA), Justice K S Hegde Charitable Hospital, Nitte (Deemed to be University), Mangaluru 575018, India.
Mazhuvanchery Kesavan UnnikrishnanDepartment of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangaluru 575018, India.
Jaclyn Drishal DsouzaDepartment of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangaluru 575018, India.
Ali Davod ParsaSchool of Allied Health, Anglia Ruskin University, Chelmsford CM11SQ, UK.ORCID 0000-0001-7390-4308
Russell KabirSchool of Allied Health, Anglia Ruskin University, Chelmsford CM11SQ, UK.ORCID 0000-0001-9257-2775
Ranjit SahDepartment of Microbiology, Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu 44600, Nepal.ORCID 0000-0002-2695-8714
Nitte University · INAnglia Ruskin University · GBDr. D. Y. Patil Medical College, Hospital and Research Centre · INK S Hegde Medical Academy · INPost Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The current study aimed to identify the perceptions and issues regarding the affordability, availability, and accessibility of COVID-19 vaccination and determine the extent of vaccine hesitancy among non-vaccinated individuals. Methods: A Prospective cross-sectional study was conducted among 575 individuals for a period of six months. All the relevant information was collected using the peer-validated survey questionnaire. An independent t-test was applied to check the association between variables. Results: Among 575 participants, 80.8% were vaccinated, and 19.2% were non-vaccinated. Among the vaccinated, 35.1% were vaccinated in private centres and 64.9% in public health centres (PHC). In total, 32% had accessibility issues and 24.5% had availability issues. However, responders vaccinated at PHC were having more issues in comparison to other groups which was statistically significant (p < 0.05). Among the 163 privately vaccinated participants, 69.9% found it completely affordable. Another 26.9% and 3.1% found vaccines partly affordable and a little unaffordable. Among the 110 non-vaccinated, 38.1% were found to be vaccine-hesitant. Conclusions: Individuals vaccinated at PHC experienced issues such as long waiting times, unavailability of doses, and registration. Further, a significant level of hesitancy towards COVID-19 vaccines was observed. The safety and efficacy of COVID-19 vaccines contributed to negative attitudes.

Indexed as

accessibilityaffordabilityavailabilityCOVID-19vaccine hesitancy

Identifiers

PMID36560419
PMCPMC9785313
OpenAlexW4310037828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.